Gelesis Holdings, Inc. (GLSHQ)

USD 0.0

(0.0%)

EBITDA Summary of Gelesis Holdings, Inc.

  • Gelesis Holdings, Inc.'s latest annual EBITDA in 2022 was -48.34 Million USD , down -41.83% from previous year.
  • Gelesis Holdings, Inc.'s latest quarterly EBITDA in 2023 Q2 was -5.05 Million USD , down -114.35% from previous quarter.
  • Gelesis Holdings, Inc. reported an annual EBITDA of -87.72 Million USD in 2021, down -39135.47% from previous year.
  • Gelesis Holdings, Inc. reported an annual EBITDA of -15.29 Million USD in 2020, down 0.0% from previous year.
  • Gelesis Holdings, Inc. reported a quarterly EBITDA of -2.35 Million USD for 2023 Q1, up 90.2% from previous quarter.
  • Gelesis Holdings, Inc. reported a quarterly EBITDA of N/A for 2022 FY, down -41.83% from previous quarter.

Annual EBITDA Chart of Gelesis Holdings, Inc. (2022 - 2020)

Historical Annual EBITDA of Gelesis Holdings, Inc. (2022 - 2020)

Year EBITDA EBITDA Growth
2022 -48.34 Million USD -41.83%
2021 -87.72 Million USD -39135.47%
2020 -15.29 Million USD 0.0%

Peer EBITDA Comparison of Gelesis Holdings, Inc.

Name EBITDA EBITDA Difference
Eiger BioPharmaceuticals, Inc. -71.03 Million USD 31.942%
Nanobac Pharmaceuticals, Incorporated -5.92 Million USD -715.428%
SQZ Biotechnologies Company -64.14 Million USD 24.625%
Evofem Biosciences, Inc. -17.37 Million USD -178.33%
Santhera Pharmaceuticals Holding AG 94.03 Million USD 151.411%
Mesoblast Limited -62.38 Million USD 22.51%
Propanc Biopharma, Inc. -1.53 Million USD -3047.426%
Genus plc 73.7 Million USD 165.598%
VioQuest Pharmaceuticals, Inc. -6.61 Million USD -631.239%
CNBX Pharmaceuticals Inc. -3.54 Million USD -1263.012%
Marizyme, Inc. -34.28 Million USD -41.027%
ContraFect Corporation -64.99 Million USD 25.62%
Nymox Pharmaceutical Corporation -8.77 Million USD -451.14%
PsyBio Therapeutics Corp. -4.52 Million USD -968.138%
Sienna Biopharmaceuticals, Inc. - USD Infinity%
RegeneRx Biopharmaceuticals, Inc. -1.4 Million USD -3348.832%
Intellipharmaceutics International Inc. -2.64 Million USD -1728.208%
AXIM Biotechnologies, Inc. -2.32 Million USD -1980.454%
MultiCell Technologies, Inc. -518.04 Thousand USD -9232.376%
Accustem Sciences Inc. -3.74 Million USD -1190.459%
RVL Pharmaceuticals plc -48.22 Million USD -0.247%
EV Biologics, Inc. -1.26 Million USD -3715.388%
Q BioMed Inc. -617.62 Thousand USD -7727.689%
Emmaus Life Sciences, Inc. 3.57 Million USD 1453.471%
Neon Bloom, Inc. -632.4 Thousand USD -7544.773%
Mosaic ImmunoEngineering Inc. -2.28 Million USD -2016.272%
Biomind Labs Inc. -1.03 Million USD -4573.147%
TetraLogic Pharmaceuticals Corporation - USD Infinity%
Pharming Group N.V. 9.87 Million USD 589.481%
Oncotelic Therapeutics, Inc. -7.16 Million USD -575.103%
Skye Bioscience, Inc. -13.54 Million USD -256.862%
Therapeutic Solutions International, Inc. -1.48 Million USD -3150.344%
THC Farmaceuticals, Inc. -25 Thousand USD -193284.0%
Arch Therapeutics, Inc. -3.88 Million USD -1144.645%
IMV Inc. -35.52 Million USD -36.096%
Acro Biomedical Co., Ltd. -15.86 Million USD -204.643%
Curative Biotechnology, Inc. -2.5 Million USD -1832.324%
GB Sciences, Inc. -1.41 Million USD -3304.924%
Alpha Cognition Inc. -9.7 Million USD -398.125%
HST Global, Inc. -5303.00 USD -911572.638%
CSL Limited 4.78 Billion USD 101.01%
Halberd Corporation -74.27 Thousand USD -64987.037%
Enzolytics Inc. -2.12 Million USD -2178.291%
Resverlogix Corp. -11.74 Million USD -311.736%
Affymax, Inc. -14.29 Million USD -238.202%
SYBLEU INC -141.57 Thousand USD -34049.649%
Nuo Therapeutics, Inc. -3.06 Million USD -1478.379%
argenx SE -216.02 Million USD 77.62%
MetaStat, Inc. - USD Infinity%
Northwest Biotherapeutics, Inc. -55.33 Million USD 12.637%
Enzon Pharmaceuticals, Inc. 1.21 Million USD 4072.555%
Arno Therapeutics, Inc. - USD Infinity%
RespireRx Pharmaceuticals Inc. -1.49 Million USD -3125.419%
GeneThera, Inc. - USD Infinity%
Inhibitor Therapeutics, Inc. 378.84 Thousand USD 12861.453%
AVAX Technologies, Inc. -6.11 Million USD -690.918%
Zenith Capital Corp. -8.6 Million USD -461.771%
Genscript Biotech Corporation -248.71 Million USD 80.562%
Ember Therapeutics, Inc. -17.42 Thousand USD -277415.642%
Anthera Pharmaceuticals, Inc. - USD Infinity%
Sigyn Therapeutics, Inc. -2.44 Million USD -1876.161%
WPD Pharmaceuticals Inc. -176.02 Thousand USD -27365.517%
American Oriental Bioengineering, Inc. -39.63 Million USD -21.972%
Provectus Biopharmaceuticals, Inc. -2.89 Million USD -1571.527%
Adynxx, Inc. - USD Infinity%
Helix BioMedix, Inc. -1.04 Million USD -4520.61%
GlobeStar Therapeutics Corporation 6724.00 USD 719106.544%
VitaSpring Biomedical Co. Ltd. - USD Infinity%
Capstone Therapeutics Corp. -1.74 Million USD -2662.63%
Cotinga Pharmaceuticals Inc. -1.92 Million USD -2416.827%
BioStem Technologies, Inc. -7.55 Million USD -540.035%
ONE Bio Corp. 13.61 Million USD 455.145%
Reve Technologies, Inc. -181.08 Thousand USD -26597.517%
Burzynski Research Institute, Inc. - USD Infinity%
Wesana Health Holdings Inc. -2.05 Million USD -2250.316%
Agentix Corp. -1.37 Million USD -3424.388%
LadRx Corporation 412.28 Thousand USD 11826.411%
Cell Source, Inc. -4.27 Million USD -1031.555%
ProtoKinetix, Incorporated -367.22 Thousand USD -13065.369%
Regen BioPharma, Inc. 1.46 Million USD 3397.916%
Regen BioPharma, Inc. -936.94 Thousand USD -5059.939%
NovAccess Global Inc. -1.03 Million USD -4572.027%
Endonovo Therapeutics, Inc. 8.85 Million USD 646.048%
Itoco Inc. -1.86 Million USD -2486.738%
Rasna Therapeutics, Inc. -379.62 Thousand USD -12635.367%
Pathfinder Cell Therapy, Inc. -1.11 Million USD -4232.079%
Kadimastem Ltd -2.62 Million USD -1742.187%
Oncology Pharma Inc. - USD Infinity%
Institute of Biomedical Research Corp. -239.15 Thousand USD -20115.764%
CytoDyn Inc. -18.02 Million USD -168.157%
Claritas Pharmaceuticals, Inc. - USD Infinity%
NDT Pharmaceuticals Inc. -79.02 Thousand USD -61075.012%
Mobile Lads Corp. -2.24 Million USD -2057.187%
NanoSphere Health Sciences Inc. -12.22 Thousand USD -395238.948%
Qrons Inc. -40.08 Thousand USD -120520.743%
Alseres Pharmaceuticals, Inc. -485.67 Thousand USD -9854.332%
Advanced Proteome Therapeutics Corporation - USD Infinity%
Nascent Biotech, Inc. 527.43 Thousand USD 9266.283%
Rebus Holdings, Inc. -951 Thousand USD -4983.701%
ImmunoCellular Therapeutics, Ltd. -1.06 Million USD -4452.311%
International Stem Cell Corporation 202 Thousand USD 24033.663%
Bioxytran, Inc. -3.82 Million USD -1165.553%
GlobeImmune, Inc. - USD Infinity%
Predictive Technology Group, Inc. - USD Infinity%
ProText Mobility, Inc. -52.64 Thousand USD -91742.705%
Cardax, Inc. - USD Infinity%
VG Life Sciences Inc. -2.46 Million USD -1863.742%
Kaleido Biosciences, Inc. - USD Infinity%
Advaxis, Inc. -35.86 Million USD -34.785%
Adhera Therapeutics, Inc. - USD Infinity%
RenovaCare, Inc. - USD Infinity%
Regnum Corp. -45 Thousand USD -107335.556%
Innovation Pharmaceuticals Inc. -2.73 Million USD -1665.741%
Neutra Corp. -181.24 Thousand USD -26574.097%
Windtree Therapeutics, Inc. -20.15 Million USD -139.823%
PureTech Health plc -11.62 Million USD -315.808%
Coeptis Therapeutics, Inc. -20.15 Million USD -139.84%
IXICO plc -707 Thousand USD -6738.19%
IntelGenx Technologies Corp. -7.68 Million USD -529.096%
CSL Limited 4.73 Billion USD 101.021%
Cellectis S.A. -92.63 Million USD 47.811%